Guofang Deng

908 total citations
59 papers, 532 citations indexed

About

Guofang Deng is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Guofang Deng has authored 59 papers receiving a total of 532 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Infectious Diseases, 36 papers in Epidemiology and 21 papers in Surgery. Recurrent topics in Guofang Deng's work include Tuberculosis Research and Epidemiology (44 papers), Mycobacterium research and diagnosis (23 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Guofang Deng is often cited by papers focused on Tuberculosis Research and Epidemiology (44 papers), Mycobacterium research and diagnosis (23 papers) and Pneumocystis jirovecii pneumonia detection and treatment (15 papers). Guofang Deng collaborates with scholars based in China, United States and Germany. Guofang Deng's co-authors include Peize Zhang, Qianting Yang, Xinchun Chen, Liang Fu, Yi Cai, Yuhong Liu, Jingtao Gao, Mingxia Zhang, Qunyi Deng and Kun Qiao and has published in prestigious journals such as The Journal of Experimental Medicine, The Journal of Immunology and PLoS ONE.

In The Last Decade

Guofang Deng

50 papers receiving 522 citations

Peers

Countries citing papers authored by Guofang Deng

Since Specialization

Citations

This map shows the geographic impact of Guofang Deng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guofang Deng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guofang Deng more than expected).

Fields of papers citing papers by Guofang Deng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guofang Deng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guofang Deng. The network helps show where Guofang Deng may publish in the future.

Co-authorship network of co-authors of Guofang Deng

This figure shows the co-authorship network connecting the top 25 collaborators of Guofang Deng. A scholar is included among the top collaborators of Guofang Deng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guofang Deng. Guofang Deng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Increasing hospital administrative efficiency via optimized office automation systems: A PDCA cycle approach 2025 ·PLoS ONE ·(unknown), Yiming Zhang, (unknown), Quan Yuan, Shuihong Chen, Na Lv, (unknown), Guofang Deng, Yuefeng Ma, Jie Xu, (unknown), (unknown)	0
2	Optimized anti-tuberculosis duration for drug-susceptible pulmonary tuberculosis-diabetes mellitus comorbidities: study protocol for a multicenter randomized controlled trial 2024 ·BMC Pulmonary Medicine ·Peize Zhang, (unknown), (unknown), (unknown), (unknown), (unknown), Yuxiang Wang, (unknown), (unknown), (unknown), Guang‐Hui Xu, Guofang Deng	0
3	Myriocin enhances the clearance of M. tuberculosis by macrophages through the activation of PLIN2 2024 ·mSphere ·(unknown), Guanggui Ding, (unknown), Hailin Lu, (unknown), Yunlong Hu, Song Liu, Huihua Zhang, Kaisong Huang, Guofang Deng, (unknown), Qing Yu, Yi Cai, Shuixiang Xie, (unknown), Xinchun Chen	1
4	Deep Amplicon Sequencing Reveals Culture-dependent Clonal Selection of Mycobacterium tuberculosis in Clinical Samples 2024 ·Genomics Proteomics & Bioinformatics ·Jiuxin Qu, Wanfei Liu, Shuyan Chen, Chi Wu, (unknown), (unknown), (unknown), (unknown), Liang Fu, Guofang Deng, (unknown), Qiang Lin, Peng Cui	3
5	Assessing the risk of TB progression: Advances in blood-based biomarker research 2024 ·Microbiological Research ·Zhaodong Li, Yunlong Hu, (unknown), Wei Gao, (unknown), (unknown), (unknown), Wenfei Wang, Chenyan Shi, Yi Cai, Guofang Deng, Xinchun Chen	1
6	Faster, higher, stronger: the evolution of clinical perspectives on pan-TB 2024 ·Liang Fu, Guofang Deng, Hongzhou Lu	0
7	Evaluation of Sulfasalazine as an Adjunctive Therapy in Treating Pulmonary Pre-XDR-TB: Efficacy, Safety, and Treatment Implication 2024 ·Infection and Drug Resistance ·Liang Fu, Wenfei Wang, Juan Xiong, Peize Zhang, (unknown), Xilin Zhang, (unknown), Qianting Yang, Zhaoqin Wang, Xinchun Chen, Guofang Deng, Yi Cai, Shenjie Tang	2
8	A cross-sectional study: a breathomics based pulmonary tuberculosis detection method 2023 ·BMC Infectious Diseases ·Liang Fu, Lei Wang, Haibo Wang, Min Yang, Qianting Yang, (unknown), (unknown), (unknown), Lei Liu, Qingyun Li, (unknown), Peize Zhang, Haibin Chen, Guofang Deng	14
9	A feasibility study of Covid-19 detection using breath analysis by high-pressure photon ionization time-of-flight mass spectrometry 2022 ·Journal of Breath Research ·Peize Zhang, (unknown), Haibin Chen, Qingyun Li, (unknown), (unknown), Lei Wang, Ting Huang, Jing Yuan, Guofang Deng, Hongzhou Lu	17
10	Linezolid-Associated Neuropathy in Patients with MDR/XDR Tuberculosis in Shenzhen, China 2022 ·Infection and Drug Resistance ·Peize Zhang, (unknown), (unknown), (unknown), Hailin Zhang, Guofang Deng, Xiaoyou Chen	17
11	Extensive Radiological Manifestation in Patients with Diabetes and Pulmonary Tuberculosis: A Cross-Sectional Study 2022 ·Therapeutics and Clinical Risk Management ·(unknown), Juan Xiong, (unknown), Yuxiang Wang, Liang Fu, Guofang Deng, Peize Zhang	11
12	Decreased mortality seen in rifampicin/multidrug-resistant tuberculous meningitis treated with linezolid in Shenzhen, China 2021 ·BMC Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), Guofang Deng, Houming Liu, Zhi Mao, (unknown), Guobao Li, Qianting Yang, Zhongyuan Wang	11
13	Insignificant difference in culture conversion between bedaquiline-containing and bedaquiline-free all-oral short regimens for multidrug-resistant tuberculosis 2021 ·International Journal of Infectious Diseases ·Liang Fu, (unknown), Feng Sun, Peize Zhang, Hui Li, Yang Li, Qianting Yang, Yi Cai, Xilin Zhang, (unknown), Xinchun Chen, Zhaoqin Wang, Lei Liu, Wenhong Zhang, Guofang Deng	21
14	Performance of Xpert MTB/RIF Ultra for the Diagnosis of Pulmonary Tuberculosis Using Bronchoalveolar Lavage Samples in People Living with HIV/AIDS (PLWHA) in China: A Prospective Study 2021 ·HIV/AIDS - Research and Palliative Care ·Peize Zhang, (unknown), Hui Wang, Yan‐Bo Wu, (unknown), (unknown), (unknown), (unknown), Guofang Deng, (unknown), (unknown), Yang Zhou, Yi‐Chu Liao	5
15	Cutting Edge: Characterization of Human Tissue-Resident Memory T Cells at Different Infection Sites in Patients with Tuberculosis 2020 ·The Journal of Immunology ·Qianting Yang, Mingxia Zhang, (unknown), Weixin Chen, (unknown), Kun Qiao, (unknown), Guofang Deng, (unknown), Jialou Zhu, Yi Cai, Xinchun Chen, Li Ma	37
16	Identification of eight-protein biosignature for diagnosis of tuberculosis 2020 ·Thorax ·Qianting Yang, Qi Chen, Mingxia Zhang, Yi Cai, Fan Yang, Jieyun Zhang, Guofang Deng, (unknown), Qunyi Deng, Guobao Li, Huihua Zhang, (unknown), Ruo‐Pan Huang, (unknown)	31
17	WHO treatment guidelines for isoniazid-resistant tuberculosis: supplement to the WHO treatment guidelines for drug-resistant tuberculosis 2018 ·Chinese Journal of Asthma ·Liang Fu, Jingtao Gao, Guofang Deng, Yuhong Liu	42
18	Activated pulmonary tuberculosis in a patient with melanoma during PD-1 inhibition: a case report 2018 ·OncoTargets and Therapy ·Wan He, Xiangmei Zhang, Wenwen Li, Cheng Kong, Yuanyang Wang, (unknown), Ruilian Xu, Guofang Deng, Peize Zhang	28
19	Empirical treatment with non-anti-tuberculosis antibiotics decreased microbiological detection in cervical tuberculous lymphadenitis 2018 ·Diagnostic Microbiology and Infectious Disease ·Youchao Dai, (unknown), (unknown), Guofang Deng, Mingxia Zhang, Qunyi Deng, Qianting Yang, (unknown), Hardy Kornfeld, Yi Cai, Xinchun Chen	3
20	Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China 2013 ·BMC Infectious Diseases ·Xiaoliang Yuan, Tiantuo Zhang, Kazuyoshi Kawakami, Jiaxin Zhu, (unknown), Hongtao Li, Guofang Deng, (unknown), (unknown)	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact